BLUE - long - possible bottom / gap play

meitshel Updated   
NASDAQ:BLUE   bluebird bio, Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

This is not a financial advice!

Couldn't find any catalyst that bothers me a bit to be honest.

Biotechs are pretty hot recently

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

14.49% short float

Block buys and Passive Stakes

Keep an eye on 1.50 key level, needs to get broken for a further upmove. You could wait for an entry until 1.50 gets broken and watch the price action there.

SL under 1.0

TP approx. 2.20

Most info on the chart.

Trade carefully!
Bluebird secures up to $175M financing amid gene therapy launches
Monday March 25, 2024
Block Trade: BLUE 620,700 @ $1.365

Friday March 15, 2024
Block Trade: BLUE 574,548 @ $1.42
Trade closed manually

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.